德特里克堡往事-钛媒体官方网站 tmtpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmtpost.com Daily Mail and Mail on Sunday newspapers.
Supply chain delays affect planned stockpile of Ebola vaccines
Supply chain delays must be addressed to speed up creation of a stockpile of vaccines against deadly Ebola disease, researchers say.
Once it is fully operational, low and lower middle-income countries will be able to access the stockpile of 500,000 doses free of charge along with support for operational costs for the rollout of immunization programmes, the vaccine alliance Gavi and partners announced Tuesday.
However, international organizations warned it could take up to three years to reach the target.
By creating a stockpile of 500,000 doses of the Ebola vaccine, available to all countries, we can help prevent loss of life and swiftly end Ebola outbreaks in the future.”
Supply delays hit planned Ebola vaccine stockpile
A health worker vaccinates a man who has been in contact with an Ebola affected person in Beni, Eastern DRC. Vaccine alliance Gavi and partners have announced a global stockpile of Ebola vaccine. Copyright: World Bank / Vincent Tremeau, (CC BY-NC-ND 2.0). This image has been cropped.
Speed read
However only 6,890 doses available because of “supply bottlenecks”
Target could take up to three years to reach because of supply issues
Share this article:
Republish
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
Search jobs 11-Dec-2020 Pediatric Vaccine Market Size to grow at a CAGR of 14.4% by 2027 | Coherent Market Insights
The Centers for Disease Control and Prevention (CDC) recommends pneumococcal conjugate vaccine for all children younger than 2 years old. Other vaccines for infants include, Hepatitis B vaccine, flu vaccine, and human papillomavirus vaccine.
The global pediatric vaccine market is estimated to account for US$ 37,567 Mn in terms of value in 2019 and is expected to reach
US$ 98,859 Mn by the end of 2027.
Global Pediatric Vaccine Market:
Drivers
Increasing funding related to vaccines is expected to boost growth of the global pediatric vaccines market over the forecast period. For instance, in January 2020, Codagenix, a company focused on R&D of vaccines and viral therapies raised US$ 20 million in a new round of financing led by Adjuvant Capital.